Intended for healthcare professionals


News feature: Costly US anticancer drugs pose problems for doctors and patients

BMJ 2008; 337 doi: (Published 14 July 2008) Cite this as: BMJ 2008;337:a778
  1. Fred Charatan
  1. 1Florida

    As the BMA calls for a royal commission to consider copayments for cancer drugs in the UK, Fred Charatan looks at the problem in the US

    The high cost of anticancer drugs is posing serious problems for patients and doctors in the United States. Even patients who are insured face difficulties because of the expense of copayments.

    The American Cancer Society said that the cost of cancer care in the US rose by 25% between 2004 and 2007, from $72bn to $89bn (£45bn; €56bn), partly because of the increased cost of drugs.

    The American Society of Clinical Oncology is so concerned about the cost of drugs that it has set up a task force to help doctors discuss costs with patients. It is expected to …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription